156 related articles for article (PubMed ID: 1708746)
1. Vitronectin and proliferative intraocular disorders. II. Expression of cell surface receptors for fibronectin and vitronectin in periretinal membranes.
Weller M; Wiedemann P; Bresgen M; Heimann K
Int Ophthalmol; 1991 Mar; 15(2):103-8. PubMed ID: 1708746
[TBL] [Abstract][Full Text] [Related]
2. [Vitronectin and fibronectin receptors in proliferative retinal diseases].
Esser P; Weller M; Heimann K; Wiedemann P
Fortschr Ophthalmol; 1990; 87(4):344-7. PubMed ID: 1698696
[TBL] [Abstract][Full Text] [Related]
3. Vitronectin and proliferative intraocular disorders. I. A colocalisation study of the serum spreading factor, vitronectin, and fibronectin in traction membranes from patients with proliferative vitreoretinopathy.
Weller M; Wiedemann P; Bresgen M; Heimann K
Int Ophthalmol; 1991 Mar; 15(2):93-101. PubMed ID: 1708748
[TBL] [Abstract][Full Text] [Related]
4. Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy.
Casaroli Marano RP; Preissner KT; Vilaró S
Exp Eye Res; 1995 Jan; 60(1):5-17. PubMed ID: 7536680
[TBL] [Abstract][Full Text] [Related]
5. Origin of fibronectin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Grisanti S; Heimann K; Wiedemann P
Br J Ophthalmol; 1993 Apr; 77(4):238-42. PubMed ID: 8494861
[TBL] [Abstract][Full Text] [Related]
6. The significance of vitronectin in proliferative diabetic retinopathy.
Esser P; Bresgen M; Weller M; Heimann K; Wiedemann P
Graefes Arch Clin Exp Ophthalmol; 1994 Aug; 232(8):477-81. PubMed ID: 7523258
[TBL] [Abstract][Full Text] [Related]
7. Tenascin and decorin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Hagedorn M; Esser P; Wiedemann P; Heimann K
Ger J Ophthalmol; 1993 Feb; 2(1):28-31. PubMed ID: 7679595
[TBL] [Abstract][Full Text] [Related]
8. The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy.
Casaroli Marano RP; Vilaró S
Invest Ophthalmol Vis Sci; 1994 May; 35(6):2791-803. PubMed ID: 7514582
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative retinopathy and proliferative diabetic retinopathy.
Ioachim E; Stefaniotou M; Gorezis S; Tsanou E; Psilas K; Agnantis NJ
Eur J Ophthalmol; 2005; 15(3):384-91. PubMed ID: 15945009
[TBL] [Abstract][Full Text] [Related]
10. [Vitronectin: mediator of cell adhesion in proliferative vitreoretinopathy?].
Weller M; Wiedemann P; Bresgen M; Heimann K
Fortschr Ophthalmol; 1990; 87(2):221-5. PubMed ID: 1694159
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin: a new attachment protein in preretinal traction membranes.
Weller M; Esser P; Bresgen M; Heimann K; Wiedemann P
Eur J Ophthalmol; 1992; 2(1):10-4. PubMed ID: 1353387
[TBL] [Abstract][Full Text] [Related]
12. [Detection of coagulation factor XIII in the vitreous body and periretinal membranes in proliferative retinal diseases].
Bresgen M; Weller M; Heimann K; Wiedemann P
Fortschr Ophthalmol; 1990; 87(3):279-82. PubMed ID: 2198204
[TBL] [Abstract][Full Text] [Related]
13. Immunolocalization of integrins in proliferative retinal membranes.
Robbins SG; Brem RB; Wilson DJ; O'Rourke LM; Robertson JE; Westra I; Planck SR; Rosenbaum JT
Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3475-85. PubMed ID: 8056523
[TBL] [Abstract][Full Text] [Related]
14. Minireview: Fibronectin in retinal disease.
Miller CG; Budoff G; Prenner JL; Schwarzbauer JE
Exp Biol Med (Maywood); 2017 Jan; 242(1):1-7. PubMed ID: 27798121
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G, complement factor C3 and lymphocytes in proliferative intraocular disorders.
Weller M; Clausen R; Bresgen M; Heimann K; Wiedemann P
Int Ophthalmol; 1990 Jul; 14(4):277-83. PubMed ID: 2196238
[TBL] [Abstract][Full Text] [Related]
16. Cellular components of proliferative vitreoretinal membranes.
Kwak SI; Chung H; Lee J
Korean J Ophthalmol; 1991 Dec; 5(2):68-75. PubMed ID: 1812289
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT
Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
[TBL] [Abstract][Full Text] [Related]
19. Basic fibroblast growth factor mRNA, bFGF peptide and FGF receptor in epiretinal membranes of intraocular proliferative disorders (PVR and PDR).
Hueber A; Wiedemann P; Esser P; Heimann K
Int Ophthalmol; 1996-1997; 20(6):345-50. PubMed ID: 9237137
[TBL] [Abstract][Full Text] [Related]
20. Indicators of oxidative tissue damage and inflammatory activity in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.
Augustin AJ; Spitznas M; Koch F; Grus F; Böker T
Ger J Ophthalmol; 1995 Jan; 4(1):47-51. PubMed ID: 7728110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
